NVIDIA Corporation

Nvidia extended its advance on September 4, closing at $230.36 (+0.84%) on a day the broad market weakened (S&P -0.38%, Nasdaq -0.29%), a powerful relative-strength signal, with the intraday high of $234.76 decisively clearing the August 27 post-earnings high of $230.47 and leaving just 2.6% of air before the 52-week high at $236.54. The tape shifted marginally defensive at the index level (VIX ticked up 1.5% to 14.53, 10-year at 4.78%), yet NVDA outperformed on 1.03x average volume with OBV printing a new high at $1.665B — above even the earnings-gap session — confirming genuine institutional accumulation rather than a low-volume drift. Momentum is accelerating: the MACD histogram expanded from +0.47 to +0.84, RSI rose to 60.4, and price sits 15.9% above the rising 200-day EMA ($198.66). Fundamentals remain the engine: next-year EPS estimates exploded from $12.63 to $15.46 over 90 days (+22.4%) with 39 upward and zero downward revisions in the last week, the mean analyst target rose to $327.13 (+42% upside), and management's 70% FY2028 growth guide still exceeds the Street's 63% model. The ~$13B Hugging Face acquisition extends the CUDA moat into the open-source model layer, and the $35B Anthropic-Lambda deal locks in scarce power and capacity. New caution flags: the Magnificent Seven just flashed a never-before-seen negative correlation with the momentum factor as capital rotates toward memory chips and broader semis, insider selling remains heavy with zero open-market buys (CEO Huang sold 956,480 shares), and Broadcom's XPU scaling at 200%+ growth reinforces marginal custom-silicon share erosion. Overall: BUY with the 1-year at STRONG BUY; the key near-term test is clearing $236.54, and a daily close below the 200-day EMA remains the invalidation line.

Taiwan Semiconductor Manufacturing Company Limited

TSM, the dominant leading-edge foundry in Technology/Semiconductors, closed at $428.91 on September 4, 2026, up 2.86% on 12.27M shares — 1.33x the 20-day average — delivering precisely the volume-confirmed reclaim of the $419.49 SMA20 that the prior analysis demanded before adding exposure. The technical setup flipped decisively constructive: MACD crossed bullish with the histogram expanding to +0.581 from -0.235, RSI(14) jumped to 56.78 from 49.63 into bullish territory, OBV hit a series high of 142.98M, and price closed 2.2% above the SMA20/EMA50 confluence at $419.94/$417.40, ~15.9% above the rising 200-day EMA at $369.97. The macro regime stays risk-on with VIX at 14.53, though the broad tape was soft on September 4 (S&P -0.38%, Nasdaq -0.29%), making TSM's move idiosyncratic and news-driven rather than beta-driven. The news flow supplied the catalyst stack: TSMC jumped ~1.9% on plans for a three-hectare advanced-packaging support center at Baipu Industrial Park to compress supplier qualification cycles, ASML rocketed 4% on TSMC's equipment requirements nearly doubling to ~1.9x year-end levels with 2026 capex of $60-64B, ASML announced a 40% Japan workforce expansion to support TSMC's second Kumamoto fab and the August 11 Sony image-sensor partnership, and Solvay is doubling Taiwan's ultra-pure hydrogen peroxide capacity — four independent supply-chain demand signals in a single day. Fundamentals remain exceptional: forward P/E of 19.62x against 36% revenue growth and 77.4% EPS growth (PEG 0.79), FCF yield of 32.85%, net cash covering 110.11% of market cap, 6-for-6 EPS beats, and FY26 estimates up $1.30 over 90 days with 9 upward and zero downward full-year revisions. The principal counterweights are the GuruFocus GF Value of $323.43 (~25% below price), the scheduled 2-4 point gross-margin dilution from the N2 ramp and overseas fabs against Q2's record 67.7%, September seasonality, and the documented -7.3% post-earnings reaction that showed how brutally the market grades this name. Next earnings is 40 days away on October 15, 2026. We upgrade the 1-month stance to BUY on the volume-confirmed breakout, maintain BUY for 6 months, keep STRONG BUY for 1 year on the durability of the process moat and revision cycle, and raise the overall BUY score to 83 from 81 as the three-week coil resolved upward with institutional confirmation.

Visa Inc.

Visa closed at $378.40 on September 2, 2026, rebounding 1.54% from the prior session's $372.67 in a broad risk-on tape (S&P +0.46%, Nasdaq +0.45%, Russell 2000 +1.13%) as the VIX collapsed 7.0% from 16.34 to 15.20, pulling the regime back to the risk-on/neutral boundary. The one-day pullback resolved exactly as the prior analysis anticipated: price found support above the rising 20-day SMA ($369.90), reclaimed the accumulation zone, and closed just 1.86% below the August 26 record of $385.57, with RSI(14) recovering from 55.3 to 60.2 and OBV flipping from -4.1M back to +1.5M — although the MACD histogram continued compressing (+0.36 to +0.22), signaling that upside momentum needs to rebuild before the record high is credibly challenged. Fundamentals remain elite and improving at the full-year level — FY2026 EPS estimates rose to $13.228 (29 up vs 6 down revisions in 30 days) and FY2027 to $15.004 (28 up vs 4 down) — but current-quarter estimates were trimmed to $3.4292 (13 down vs 9 up), keeping the October 27 print (54 days away) the key near-term test. The freshest fundamental positive is the enhanced A2A Protect rollout with Featurespace behavioral AI, delivering up to 75% better scam detection and 40% fewer false alerts, which converts the account-to-account disintermediation threat into a new high-margin software revenue stream. The DOJ debit case remains the structural overhang: 6 million documents produced, discovery extended to January 2027, and trial expected in 2028. Sell-side posture is strengthening — RBC raised its target from $412 to $466 on August 31, Wolfe to $460, Cantor to $445 — with zero downgrades in 90 days. At $378.40 the stock trades at 32.2x trailing and 25.2x forward earnings with a 1.69 PEG and 2.89% FCF yield, a quality premium with roughly 10.8% implied upside to the $419.36 mean target. The primary risks to monitor are the DOJ's debit-fee restructuring potential, current-quarter estimate drift into earnings, opex growth of 17% outpacing revenue, and Mastercard's parallel VAS (+20%) and stablecoin (BVNK) build-out.

AbbVie Inc.

ABBV closed at $260.21 on September 3, down -0.58% from $261.72 in a session that opened at $264.00, punched to an intraday high of $264.25 — above the prior $262.97 recovery high — and then faded, a classic upper-wick rejection on just 2.75M shares (0.64x the 20-day average), the lightest session in the window. The macro backdrop turned decisively risk-on: the VIX fell 5.79% to 14.32 (below the 15 risk-on boundary), the S&P 500 rallied +1.06% to 7747.71, the Nasdaq +1.40%, and the Dow +1.18%, while the 10-year yield eased to 4.76%. The headline event was a major pipeline win: Phase 3 CERVINO data showed etentamig in relapsed/refractory multiple myeloma delivered a 74% objective response rate versus 45.7% for standard therapy with significantly improved progression-free survival and a 12-month overall survival rate of 87.9% vs. 72%, prompting the Independent Data Monitoring Committee to advise unblinding the study — a catalyst that materially strengthens the oncology narrative beyond the Imbruvica-decline drag. Fundamentals remain strong: Q2 revenue of $16.99B (+10.2% YoY) with EPS of $3.65 (+22.9% YoY), SKYRIZI/RINVOQ combined tracking to $31B+ in 2026, neuroscience up 19.8% in Q2 with Vyalev at $457M in H1 and expected to reach blockbuster status, and a 15.98x forward P/E with a 0.37 PEG. Estimate dynamics stay bifurcated — FY26 EPS was cut 16 times in 30 days to $14.01 on Apogee dilution while FY27 rose on 11 upward revisions to $16.28 (Zacks frames it as FY26 down to $14.05 and FY27 up to $16.15 over 60 days) — and sell-side posture stays bullish with Piper Sandler ($303), Wells Fargo ($300), and Wolfe (upgrade, $300) targets clustered around $300 against a $276.59 mean (6.3% upside). The 1-month view stays HOLD because the fourth probe of the $262-$266 zone failed intraday on sub-average volume with the MACD histogram still negative at -0.331; the 6-month view is BUY on estimate momentum and pipeline catalysts; and the 1-year view is STRONG BUY on valuation, franchise durability, the etentamig optionality, and a 2.64% yield — with the $252-$258 SMA20/EMA50 entry zone still offering roughly 5.3:1 tactical risk/reward to the exit midpoint.

Microsoft Corporation

Microsoft closed at $499.70 on September 4, 2026, down 2.04%, giving back most of the prior session's +2.67% shelf reclaim and closing just $2.30 above the $497.40 breakout shelf it had repaired 24 hours earlier — a failed follow-through that keeps the near-term picture unresolved. The macro regime softened at the edges: VIX ticked up 1.47% to 14.53 (still inside the risk-on band), the S&P 500 fell 0.38%, the Nasdaq dropped 0.29%, and the 10-year rose to 4.78%. The new information flow was two-sided: Stifel raised its target 18% to $530 on Copilot's step-change in engagement (weekly active use now on par with Outlook and Teams) and expected Azure efficiency gains to reduce margin drag, but kept a Hold rating because the risk-reward at these levels is insufficient; separately, Azure's $101.9B annual revenue and $29.4B quarterly revenue were made directly comparable to AWS and Google Cloud for the first time, yet the stock fell on the disclosure because Azure costs, margins, and ROIC remain undisclosed. The most consequential development may be external: the rolling 21-session correlation between the Magnificent Seven ETF and the momentum factor turned negative for the first time on record, signaling genuine capital rotation toward memory, semiconductors, and broader S&P breadth — a headwind for mega-cap leadership that MSFT cannot control. Estimates momentum remains net positive: FY+1 EPS estimates rose to $23.57 over 90 days (from $22.62), the +1q revision picture actually improved this cycle (13 up vs 7 down in the last 7 days versus 8 down over 30 days previously netting worse), and the ratings mix is intact at 14 Strong Buy/38 Buy/3 Hold with zero Sells. Technically, the shelf held on a closing basis but momentum regressed: the MACD histogram re-deepened from -1.85 to -2.36 after its one-session upturn was invalidated, RSI fell from 66.41 to 59.60, and OBV slipped to +246.8M from +264.3M — the bullish crossover remains unconfirmed and the decay has resumed. The mean analyst target of $572.92 implies 14.6% upside from $499.70, a wider cushion than last cycle simply because the price pulled back. We downgrade the 1-month view to HOLD pending either a confirmed MACD crossover or a decisive hold of $497.40-$498 on volume, maintain BUY at 6 months, and keep STRONG BUY at 1 year where fundamentals, disclosed Azure scale, and 21.2x forward pricing for 31.7% growth dominate — with the stop unchanged at $487.31 and the structural floor at $479.45.

The Goldman Sachs Group, Inc.

Goldman Sachs closed at $1,038.61 on September 4, adding a modest 0.07% after the powerful 3.34% September 3 reversal, and the decisive new technical development is that the MACD histogram has now flipped positive (+0.68 from -0.55), completing the bullish crossover foreshadowed a day earlier — with price holding above both the SMA20 ($1,029.10) and EMA50 ($1,029.01) for a second consecutive session and RSI firming to 52.02. The $996.97-$996.80 double-bottom has now held and been followed by two constructive closes, converting the setup from defensive to early-stage recovery, though September 4 volume of 1.43M shares (0.79x the 20-day average) means institutional confirmation above $1,063.52 is still missing. The macro regime remains risk-on with VIX at 14.53, but the 10-year yield ticked up to 4.78% and the S&P 500 slipped 0.38% on September 4. Fundamentals remain exceptional: Q2 2026 EPS of $20.98 beat by 44.3% on record net revenues of $20.34B, the beat streak stands at 6/6 quarters, FY2026 consensus EPS of $70.77 carries 21 upward revisions and zero cuts in 30 days, and the Q3 bar sits at $16.43 (raised from $14.09 in a month). News flow on September 4 reinforced the fee-engine thesis: GS is named in a prominent role on Anthropic's ~$15B pre-IPO revolving credit facility alongside Morgan Stanley, JPMorgan and Citi — fresh evidence that the AI IPO-financing pipeline is converting from framework to signed commitments — while its NEOS acquisition ($30B in AUM across 19 options-based income ETFs) positions GSAM as the eighth-largest active ETF provider. Offsetting this, GS's own Delta One desk published a cautionary note on collapsing AI token prices ($0.97 per million tokens, -29% in August alone) raising compute-oversupply risk — a signal that the bank itself is flagging valuation fragility in the very theme powering its fee narrative. With earnings 38 days out (October 13) and a demanding consensus bar, we maintain BUY at all horizons: the 1-month view rests on the confirmed momentum crossover and the tested $997 floor, while the 6-12 month case rests on franchise quality, estimate momentum, AI-financing conversion, and a still-reasonable 14.03x forward multiple with ~10% upside to the $1,141.65 mean target. The key risk to monitor is a failure of follow-through: without a volume-confirmed close above $1,063.52, this remains a recovery within a distribution range, and a close below $996.97 would invalidate the setup entirely.

Quanta Services, Inc.

Quanta Services closed at $624.41 on September 4, up 0.70%, and delivered the confirmation the prior analysis demanded: the close cleared the $622.60 lower-high pivot and the $623 trigger level for the first time since the $722.31 August 17 peak, with an intraday high of $633.80 that eclipsed the prior session's $626.95 — and it did so against a soft tape (S&P 500 -0.38%, Nasdaq -0.29%, Dow -0.51%, VIX up 1.47% to a still-complacent 14.53, 10-year at 4.78%), a display of relative strength that matters more than the absolute move. Price is now 20.8% below the 52-week high of $788.75, 8.1% above the rising EMA200 at $577.55, and 3.2%/4.0% below the SMA20 ($645.06) and EMA50 ($650.24) that define the full trend-reclaim zone. The caveat is participation: September 4 volume of 639K was just 0.60x the 20-day average, so institutions have not yet confirmed the reversal. The fundamental thesis continues to strengthen: the September 4 Zacks piece shows an ABR of 1.31 across 26 brokers (22 Strong Buy), the Zacks Consensus for 2026 EPS ticked up again to $16.37 supporting a Zacks Rank #1, and EMCOR's September 4 feature (record $17.14B RPOs, +44% YoY, raised 2026 guidance to $32-$33.25 EPS) confirms demand is broad-based across the complex — with Q2 having already delivered PWR operating margin expansion to 7.3% from 5.5%. The estimate wave remains exceptional: the current-quarter consensus of $5.02 is up from $4.24 30 days ago, FY2026 at $16.73 from $14.02, FY2027 at $19.64 from $16.49, with zero downward revisions anywhere. Technically, the MACD histogram has now contracted four straight sessions (-7.89 to -2.37), RSI recovered to 45.38, and OBV rose to 15.35M — downside momentum is decaying faster than price is advancing. We maintain BUY across horizons with the score nudged to 78: the near-term setup has upgraded from 'reversal attempt' to 'confirmed pivot break pending volume,' while the 6-12 month case rests on unmatched demand visibility, margin expansion, and a relentless revision cycle. The invalidation line remains a confirmed close below the $593.72 shakeout low and the EMA200 at $577.55, with the July 29 low at $554.12 as the structural backstop.

Chevron Corporation

Chevron pulled back 1.29% to $208.60 on September 4, 2026, retreating from within 1.6% of its 52-week high ($214.71) and giving the first constructive entry signal in two weeks — RSI(14) cooled from 71.15 to 64.87 and price compressed to just 2.9% above the rising 20-day SMA ($202.64) after a 11.2% one-month run. The tape is risk-on (VIX 14.53) but indexes eased (S&P 500 -0.38%), the 10Y sits at 4.78%, and the Gabelli Q2 letter notes May CPI at 4.2% with the market pricing roughly 1.5 Fed hikes by year-end under Chair Warsh — a stagflationary mix that continues to channel capital into energy cash flows. Fundamentals remain exceptional: six-for-six earnings beats with a record Q2 ($6.06 EPS, +8.8% surprise, $12.1B profit), FY26 estimates revised up from $14.53 to $16.04 over 90 days with 19 upward revisions in the past 30, and fresh target raises from Piper Sandler ($243 street-high), BMO ($235), and Wells Fargo ($230) after the September 2 Venezuela announcement supporting $7B+ of investment toward 600,000 bpd of sub-$20/bbl Orinoco barrels. The mean analyst target of $221.21 now implies ~6.0% price upside plus the 3.37% yield — materially better entry math than at $211.32. But two new negative catalysts demand respect: President Trump summoned Chevron and other refiners to the White House demanding lower gasoline prices with gas above $4/gallon and midterms two months away (no short-term supply fix exists — utilization ran 98% with 7-8M bpd of global refining capacity offline, driving all-time-high crack spreads), and a second report shows Big Oil executives are wary that the administration's Venezuela foray is 'about more than drilling.' The technical uptrend is intact (golden cross, MACD line 5.28 above signal 4.94), though the histogram decelerated to +0.33 and the marginal rally ran on 0.69x average volume. CVX is a Buy on all horizons — the reset toward the $203-207 entry shelf improves timing — with the political-refining overhang and crude reversal risk as the key monitors, and $198.50 as the structural stop.

Super Micro Computer, Inc.

SMCI surged 4.55% to $39.59 on September 4, breaking above the $38.50-$40.60 supply zone intraday with a $40.91 high before closing just below $40 resistance — the strongest session since the August 12 earnings blowout — on 53.3M shares (0.97x the 20-day average of 54.8M), a decisive volume improvement over the prior sub-average tape. The technical structure materially improved: the MACD histogram narrowed sharply to -0.081 from -0.193 with the MACD line (1.72) nearly recrossing above the signal line (1.80), RSI rose to 62.7 deeper into bullish territory, OBV jumped to 527.4M (now just ~9% below the August 14 peak of 581.4M), and the EMA50 ($33.96) sits only $0.24 below the EMA200 ($34.19) with the golden cross effectively imminent. The market regime stays risk-on with VIX at 14.53 and the 10-year yield at 4.78%, even as the S&P 500 (-0.38%) and Nasdaq (-0.29%) drifted lower — SMCI's move was idiosyncratic and news-driven, the best kind. News flow on September 4 was predominantly constructive: Dell hit a 52-week high on a record $95B AI backlog and $60.9B in quarterly AI server orders with FY27 AI revenue guided to $74B (3x prior year), powerfully validating end-demand for the entire AI server complex; Zacks highlighted SMCI's forward P/S of 0.34x versus the industry's 3.05x, a Value Score of B, and detailed FY26 revenue of $39.1B, a record $60B+ order quarter, Q1 FY27 revenue guidance of $14.5-15.5B, and capacity scaling to 6,000+ racks per month with 240kW racks in volume production. The estimate revision cycle remains exceptional — current-quarter EPS consensus is $1.04 versus $0.67 ninety days ago (+55%), current-year $4.34 (+33%), and FY28 $4.87 (+69%) — with 4-5 upward revisions versus 0-1 downward across periods. The critical counterweights persist: the GuruFocus piece correctly frames the margin question (FY26 gross margin slipped to 10.8% from 11.1% despite 78% revenue growth, and 75% of Q4's 17.6% margin improvement came from favorable contract mix), StockStory noted Q4 revenue actually missed consensus by 3.8% even as EPS beat, and TTM FCF remains -$8.25B with an FCF yield of -32.2%. With 59 days to the November 3 earnings report, SMCI-specific event risk is low, but 18.0% short interest, an open export-control investigation, and a $15-$60 analyst target spread keep headline risk elevated. The fundamental thesis — a 55-69% revision cycle, $60B+ backlog, and ~7.4x forward P/E against 93% revenue growth — drives the overall, 6-month, and 1-year Buy ratings, while the 1-month view stays Buy rather than Strong Buy because the breakout must still be confirmed with a close above $40.60; the preferred entries are now a pullback into the rising SMA20 zone at $36.50-$38.50 or a volume-backed close above $40.60, with the invalidation level tightened to a close below the EMA200 at $34.19.

Mastercard Incorporated

Mastercard closed at $579.21 on September 4, 2026, falling -1.11% on a day when the S&P 500 lost only -0.38%, the Nasdaq -0.29%, and the Dow -0.51% — a second consecutive session of relative weakness that has now turned into a technical breakdown: price closed below the rising 20-day SMA ($579.68), the MACD histogram widened for a fourth straight session from -0.74 to -1.05 to -1.45 to -2.15 (MACD $8.73 versus signal $10.88), RSI collapsed from 57.70 to 52.91, and OBV deteriorated to -7.64M on just 0.64x the 20-day average volume. The macro regime remains Risk-On but is cracking at the edges: the VIX ticked up 1.47% to 14.53 and the 10-year yield edged to 4.78%. Fundamentals remain emphatically sound: Q2 2026 EPS of $5.04 beat by 5.5%, revenue grew 14.1% to $9.3B, VAS grew 20% YoY to 41.2% of net revenue, and FY0/FY1 estimates keep climbing ($19.93 and $23.03 with 33 upward versus 1 downward 30-day revisions each). The persistent crack is the +1q estimate at $5.17, which absorbed 17 downward versus 9 upward revisions in the last 7 days — a widening warning flag into the October 29 Q3 report (54 days away). News flow is constructive: Mastercard launched the inaugural agentic-commerce Start Path cohort (22-23 startups including SolvaPay and Crossmint), Circle's Arc Mainnet launch on September 16 will include MA as a stablecoin settlement expansion partner, and Eagle Capital's Q2 letter flagged MA as a durable payments-duopoly holding. We maintain BUY overall — the low-teens revenue / high-teens EPS algorithm, 100% beat rate, and ~14.9% consensus upside justify 12-month conviction — but the 1-month view stays HOLD with a defensive tilt because the breakdown below the 20-day SMA on persistent relative weakness argues against chasing; accumulate on pullbacks toward $560-576 (50-day EMA at $559.83) or on a confirmed high-volume reclaim of $588-595. Key risks: a heavy-volume close below $553, further +1q estimate erosion, a 10-year yield break above 5%, or adverse DOJ/CCCA headlines.

Citigroup Inc.

Citigroup closed at $138.14 on September 3, 2026, surging 2.83% from $134.34 on 11.72M shares — 1.39x the 20-day average volume — with an intraday high of $138.55, delivering the volume-confirmed breakout the prior analysis was waiting for: price decisively cleared the SMA20 at $134.64, the prior swing high at $136.20, and pushed toward the August 17 high at $140.88. The technical picture flipped decisively bullish in one session: the MACD histogram turned positive at +0.250 (first bullish crossover since the August 20 breakdown, from MACD -0.088 above its signal at -0.338), RSI(14) jumped to 59.25, and OBV hit 414.3M — a fresh dataset high above the August 14 peak of 410.3M — confirming institutional accumulation rather than a low-volume drift. The macro tape is now fully risk-on: VIX fell 5.79% to 14.32, the S&P 500 gained 1.06%, the Nasdaq 1.40%, and the 10-year yield eased to 4.76%. The news flow split constructively: the September 3 Zacks analysis validated the capital-return execution ($12.4B returned in H1, $26B remaining buyback capacity, CET1 12.8% ~120bps above requirements, Banamex releasing ~$5B), directly counterweighting the September 2 Goldman Sachs G-SIB note that projects sector excess capital collapsing from $78B toward a potential $21B deficit by 2029 with C among the largest Q2 score increases. Fundamentals remain deeply undervalued at 10.72x forward earnings, a 0.60 PEG, and 1.20x book, with FY2026 estimates rising 3.8% over 90 days even as Q3 ($2.62) and Q4 ($2.33) get trimmed — a divergence consistent with conservative resetting given the 83% beat rate. Earnings are 39 days away (October 13); the confirmed breakout plus risk-on regime support the Buy stance, but the G-SIB capital math and near-term estimate cuts mean the long-term STRONG BUY case rests on earnings growth and AI-driven efficiency rather than per-share buyback accretion alone.

Sandisk Corporation

SNDK exploded higher on September 4, closing at $1,740.00 — up 11.9% on the day, at the intraday high — in a decisive, volume-confirmed breakout through the $1,600-$1,610 resistance band that had capped the stock three times in five weeks. Volume of 16.22M shares was 1.22x the 20-day average, the first above-average session after four sub-average ones, and the memory complex rallied broadly (Micron +4%, SK hynix +3%) on Dell's disclosure of a $95B AI-server backlog, easing Treasury yields, and a Lynx Research note assigning SNDK a $2,450 target (41.9% upside from $1,727). The tape was memory-specific: the S&P 500 and Nasdaq actually closed lower (-0.38% and -0.29%), proving capital is rotating into the memory theme rather than merely riding a beta wave. Technically, the breakout is textbook: MACD histogram re-expanded from +8.45 to +19.44, RSI jumped to 61.24 — firmly in bullish territory with room before overbought — and price is now 14.3% above the rising EMA50 ($1,522.92) and 72.7% above the EMA200 ($1,007.21) in an intact golden-cross structure. Fundamentals received another demand proof-point in Dell's $95B AI-server backlog, layered on last week's Broadcom disclosure that memory supply constrains its $115B FY27/$230B FY28 AI roadmap and expectations of NAND prices up ~60% this quarter; estimate revisions also healed at the margin, with next-quarter revision counts flipping from 8-down/4-up to 2-up/0-down over the last 7 days. The valuation remains bifurcated: 6.57x forward EPS against 23.61x trailing and 12.58x sales, with the mean analyst target of $2,125.09 implying 22.1% upside and Lynx's $2,450 target now validated by the breakout. Risks are real and quantified: 8.24% short interest, WDC's 29.86M-share distribution, the $31B Yokkaichi/Kitakami capex seeding future supply, and the standing possibility that this is a cycle peak dressed as a new cycle. With earnings 62 days away (November 6), the 1-month setup is now flow- and momentum-driven, and the invalidation level shifts up from $1,344.29 toward the $1,600 breakout shelf — a daily close back below $1,600 on volume would negate the breakout, while a close below $1,435.61 would break the August structure entirely.

HSBC Holdings plc

HSBC delivered a second consecutive follow-through day: after the September 2 break above $104.38 and the September 3 gap-up to $106.46, the stock added another +0.61% to close at $107.11 on September 4, tagging an intraday high of $107.43 and finishing just 0.75% below the $107.92 52-week high at the 98.13% mark of its 52-week range, with 1.21M shares traded (1.18x the 20-day average). Technically the advance is strengthening: the MACD histogram expanded to +0.161 from +0.023 (MACD line $1.037 well above signal $0.876), RSI(14) reached 66.6 approaching overbought, OBV rose to 34.19M, and ATR compressed to $1.478 (~1.38% of price), signaling a low-volatility grind into resistance — though OBV still sits below mid-August levels (~35-36M) and far under the late-July 41.65M peak, so institutional confirmation remains incomplete. The macro regime stays risk-on with the VIX at 14.53, but the 10-year yield ticked up to 4.78%, and HSBC's own strategists raised Treasury forecasts (nearly even odds of a 25bp September hike, 10-year at 4.65% end-2026) — a direct long-end headwind the company itself is flagging. Fundamentals are strong but fully in the price: 11.31x forward P/E and a 0.92 PEG versus an optically rich 8.50x book on 13.1% ROE, the $106.08 mean analyst target now exceeded by 1.0%, outer-horizon EPS estimates still being cut (next-quarter -4.6% weekly, FY2026 -3.0%), and a polarized recommendation set that now includes a strong sell. The disciplined play is to hold core positions, resist chasing within 0.75% of the 52-week high, and buy pullbacks into $103-$105.5 (SMA20 at $103.79, broken resistance at $104.38), with a tactical stop at $100.5 and the exit trigger at $107.92 extending to the $115.24 high target. Next earnings are 52 days away (October 27), so binary event risk is low; the key monitors are the September FOMC and long-end yields, China insurance-tax enforcement, credit-cost creep, and Hong Kong CRE exposure.

Micron Technology, Inc.

Micron delivered the breakout this analysis has been waiting for: on Sep 4 the stock gapped above the thrice-rejected $969.44/$970.85 resistance and closed at $1,016.59, up 6.1% on 34.9M shares — 1.26x the 20-day average volume and the first volume-confirmed advance of the entire recovery, resolving the coil that had compressed ATR from $90.54 on Jul 31 to $54.84. The MACD histogram more than doubled from +2.12 to +5.87 (largest expansion since mid-August), RSI(14) jumped from 53.49 to 60.15, and OBV rose to 1.056B, all confirming genuine accumulation rather than the 0.69-0.87x light-volume drift of prior sessions. The catalyst was tangible, not just sentiment: OpenAI's GPT-6 Astra launch reignited the AI-infrastructure trade, Dell disclosed a $95B AI-server backlog, Broadcom reported AI semiconductor revenue of $16.7B (+221% YoY), and Lynx Research initiated coverage of the memory breakout with a $1,325 MU target. This happened on a soft tape (S&P -0.38%, Nasdaq -0.29%, VIX up to 14.53), underscoring that the move is idiosyncratic to memory. The fundamentals remain extraordinary — FQ3 revenue of $41.46B (+346% YoY), 84.9% non-GAAP gross margin, $18.3B adjusted FCF, FQ4 guidance of ~$50B revenue at ~86% gross margin, 2026 HBM sold out, and a significant portion of 2027 reserved — with FY-forward EPS revised up 51% in 90 days to $155.03, leaving the stock at just 6.56x forward GAAP earnings despite a 12.72x trailing P/S. Risks are unchanged but now more consequential: earnings on Sept 30 (25 days away) is the first test of the ~$31 quarterly EPS run-rate, the Taiwan labor dispute remains routed through mandatory mediation with unions demanding 15% of operating profit as recurring bonuses, Chinese capacity could ramp earlier than expected, and the stock now trades ~64% above the $618.17 GF Value cited by GuruFocus. All three horizon views are BUY: the 1-month view is upgraded from HOLD on the confirmed breakout with room to the $1,036/$1,255 highs, while 6-month and 1-year conviction rests on the contracted AI memory thesis and the wide gap between the $1,513 mean target and spot. The key monitoring points are a failure to hold the $970.85 breakout level on any retest, Taiwan mediation headlines, and any sign the +1y revision slope (flat at $155.03 over the last 30 days) turns down into the print.

Salesforce, Inc.

Salesforce closed Friday at $259.23, down 1.97%, marking the second consecutive fade from the post-earnings highs after Thursday probed $268.27 and Friday opened at $263.36 before sliding to a $257.82 low — the clearest intraday distribution hint of the move, though on light volume (10.3M, just 0.63x the 20-day average of 16.4M), which reads more as healthy digestion than institutional exit. The stock is up 38.8% over one month and 49.3% YTD, sits 3.7% below the $269.11 52-week high at the 92nd percentile of its 52-week range, and has now held seven sessions above $250 since the defining August 27 gap from $205.62 to $252.05 on 3.9x average volume. Momentum is decelerating at the margin: RSI(14) rolled from 81.89 to 76.63 and the MACD histogram contracted for a second straight session (5.15 to 4.30), the first formal deceleration sequence of the post-earnings thrust, while OBV slipped to -83.0M. The fundamental case remains strong but gained important nuance this week: Cantor Fitzgerald raised its target to $300 (from $250) on the open-platform thesis that AI will embed rather than disintermediate Salesforce, while a September 4 Insider Monkey analysis correctly flagged that Informatica contributed roughly 4.5 percentage points of the 11% reported revenue growth and that ~$1.1B of the $3.9B Agentforce/Data 360 ARR came from Informatica — meaning organic growth is materially lower than headline optics. The estimate wave is still decisively positive (FY consensus EPS $16.28 versus $14.14 seven days ago, zero current-period downgrades in 30 days), but the +1q estimate at $3.545 remains below its 7-days-ago level of $3.632. The macro backdrop improved meaningfully: VIX fell to 14.53, and dovish Fed commentary plus a soft ADP report cut September rate-hike odds from over 60% to a coinflip — a direct tailwind for a 16.2x forward-PEG-1.07 software multiple, though the 10-year at 4.78% keeps rate sensitivity live. The thesis is BUY on a 6-12 month horizon with the mean target ~4% above price and the $300 cluster anchoring price discovery, but the 1-month rating stays HOLD: with RSI at 76.6 after a 38.8% monthly gain, a two-day fade sequence printed, and the street's fair-value models near $256, chasing here carries worse risk/reward than scaling into the $230-$240 gap-support zone.

Semtech Corporation

Semtech closed at $135.40 on September 3, up 1.16% and holding above both the SMA20 ($133.84) and EMA50 ($133.08) for a second consecutive session — the base repair that began with the September 1 intraday reversal off $124.83 is now confirmed by two clean closes above the medium-term averages, with the September 3 dip to $126.75 again testing and defending the $127-130 support cluster. The macro tape turned decisively risk-on: VIX fell 5.79% to 14.32, the S&P gained 1.06%, the Nasdaq rallied 1.40%, and the Russell 2000 added 0.51% — exactly the backdrop where a 2.35-beta name catches systematic bids — though the 10-year yield at 4.76% remains a persistent multiple-compression overhang. The fundamental thesis is exceptionally strong: six consecutive EPS beats culminating in a +15.6% surprise, a Q2 FY27 beat (EPS $0.71 vs. $0.61, revenue $341.9M, +32.7% YoY), a Q3 guide of $410M revenue / ~$1.06 EPS midpoints implying ~54% YoY growth, record data center revenue of $100M (+91% YoY) with 1.6T FiberEdge share guided above 50% by fiscal 2027-end, record LoRa sales of $58M (+58% YoY), and one-directional estimate revisions — 12 upward current-quarter EPS revisions in seven days with zero downgrades anywhere, next-FY estimates up 50% to $5.84, and a 1 Strong Buy / 13 Buy / 1 Hold / 0 Sell recommendation mix. September 3 brought a media trifecta: two Zacks technical alerts broadcasting the 20-day and 50-day moving average reclaims alongside Zacks Rank #1 status, plus a Zacks 'Bull of the Day' feature arguing SMTC is 'on sale' below $130 at roughly 6x forward sales for a business growing 40%+, citing the $200B AI connectivity TAM and NVIDIA's $2B strategic investments into optical peers Lumentum, Coherent, and Marvell as thematic validation. The counterweight remains the September 2 StockStory piece flagging SMTC's ~27x forward P/E as a reason to pass, persistent insider selling (five disposals, ~$1.3M, zero buys), 9.0% short interest, and a thrice-rejected $142-150 supply zone that must be reclaimed with volume to resume the uptrend. Momentum is improving — MACD histogram expanded from +0.41 to +0.48, RSI recovered to 51.8, and OBV rebuilt to 48.8M — but the September 3 volume of 1.83M was only 0.58x the 20-day average, so the repair still lacks institutional volume confirmation. The next earnings report is 80 days away (November 23), with the October investor event (multiyear targets expected) as the interim catalyst. We maintain BUY across all horizons: the $124-125 floor has been tested and defended twice, the averages have been reclaimed, and the estimate-reset thesis is intact — but the burden of proof sits at $142.07, and a daily close below $124 remains the exit line.

Vertiv Holdings Co

Vertiv delivered the full technical confirmation the prior review demanded: after the September 3 breakout (+4.7% to $268.83 with a fresh MACD bullish crossover), the stock followed through on September 4 with a gap-up to $273.95 and a close of $280.53 (+4.35%), decisively reclaiming the 50-day EMA ($279.30) — the exact trigger that converts the recovery from 'in progress' to 'confirmed.' The advance came despite a soft tape (S&P -0.38%, Nasdaq -0.29%, Dow -0.51%, VIX up 1.5% to 14.53), demonstrating powerful idiosyncratic buying on the UIG acquisition narrative. Momentum is now firmly positive: the MACD histogram expanded from +0.57 to +1.91, RSI rose from 49.3 to 54.9 into bullish territory, and OBV improved to -34.8M, its best level in the dataset. Fundamentals are exceptional — a 100% beat rate over six quarters, FY2026 guidance implying ~37% revenue growth, a record ~$15B backlog, 21 upward versus 3 downward FY2026 estimate revisions over 30 days, and billionaire-led fund ownership rising from 28 to 32 funds including AQR ($858.2M) and Omega Advisors ($722.5M). The dominant strategic catalyst remains the ~$2.6B UIG acquisition extending Vertiv upstream into grid interconnect, microgrid controls, and behind-the-meter power, now complemented by Eaton's $242M Arkansas capacity expansion news validating the critical-power theme's demand durability. Key risks: the September 4 advance came on just 0.83x the 20-day average volume, valuation remains stretched (30.8x forward P/E versus the sector's 20.2x, 38.7x EV/EBITDA, Value Score of D) with the 10-year at 4.78%, and Amphenol (+89% IT datacom) and Super Micro (>6,000 racks/month) are buying into VRT's addressable market. With earnings 46 days away, the structure supports BUY across horizons with the stop firmly below the rising 200-day EMA ($248.48).

Tower Semiconductor Ltd.

在宣布与Oriole Networks合作进军800亿美元的AI基础设施市场后，TSEM经历了超30%的巨大突破。尽管市场处于避险模式（VIX > 25），TSEM凭借其独特的催化剂和庞大的机构交易量实现了极端超额收益。估值指标令人惊讶地合理；虽然静态市盈率达87倍，但42.6%的加速盈利增长使得PEG比率低至极具吸引力的0.83。从技术面看，该股极度超买（RSI 74.3），且远超其20日均线。鉴于VIX高企和技术面过度延伸，追高存在风险。建议在回撤至145-155美元的缺口回补区域时买入（BUY），让动能降温的同时获取AI新叙事的敞口。

Arista Networks, Inc.

ANET closed at $191.44 on Sep 3, rebounding +2.87% from $186.10 in a session that delivered exactly the reversal the prior analysis demanded: the stock pierced below the decisive Aug 20 swing low of $182.83 intraday (printing $181.27, briefly under the EMA50 at $183.28), then reversed violently to close near the session high of $192.00 — a textbook hammer reclaim of the EMA50 within an intact long-term uptrend (price now 20.5% above the EMA200 at $158.88). Momentum signals improved in sympathy: the MACD histogram narrowed for the first time in three sessions from -1.49 to -1.42, RSI(14) recovered from 47.43 back above the 50 line to 51.53, and OBV rose from 106.3M to 110.3M, though volume of 4.0M was just 0.68x the 20-day average, so the reversal lacks volume confirmation and the SMA20 ($194.26) remains unclaimed 1.5% overhead. The regime turned decisively risk-on — the VIX collapsed 5.8% to 14.32, the S&P gained 1.06% and the Nasdaq 1.40% — and unlike the prior two sessions of relative weakness, ANET outperformed the Nasdaq, suggesting the rotation-out behavior has paused. Fundamentals are unchanged and pristine: Q2 2026 delivered a 15.2% EPS beat ($1.02 vs $0.886) on record revenue of $3.04B (+37.7% YoY), Q3 guidance of ~$3.3B with 48-49% non-GAAP operating margins, a 100% beat rate across six reported quarters, FY26 consensus EPS revised up 13.1% in a month to $4.11 with 21-26 upward revisions and zero downward revisions, Zacks Rank #1 with the consensus estimate shifted up 22.82% since the print, and the PEG at 1.42. Fresh sponsorship includes Deutsche Bank's Sep 1 Buy initiation ($220 target) citing enterprise and sovereign AI, while the mean target of $241.04 implies ~26% upside and the price sits just 3.4% above the lowest Street target ($185). The bear case persists at 37.1x forward, 60.6x trailing and 47.7x EV/EBITDA in a 4.76% 10-year-yield regime, with Nokia explicitly attacking 'industry leader Arista Networks' while growing AI & Cloud revenue 105% (albeit with negative FCF of -€732M and a Zacks Hold), and the Nov 3 earnings-on-election-day compound event now 60 days out. We raise the overall score to 75 (BUY), upgrade the 1-month view to BUY on the EMA50 hammer reversal within a risk-on regime, retain STRONG BUY for 6 months on the estimate-revision machine, and keep BUY for 1 year; a daily close below $181.27 would void the reversal and force de-risking.

Bank of America Corporation

Bank of America closed at $62.68 on September 4, down -0.57% on below-average volume (25.88M shares, 0.89x the 20-day average), and the one-day SMA20 reclaim failed to hold — price closed back below the 20-day line at $62.94 after the broader tape weakened, with the S&P 500 down -0.38% to 7,718.60, the Nasdaq -0.29%, and VIX ticking up +1.47% to 14.53 while the 10-year firmed to 4.78%. The proximate catalyst was GuruFocus' Friday coverage of the 21-bank stablecoin consortium, which explicitly framed the initiative as unable to guarantee customers will abandon Tether's $180B incumbency and noted the stock sits 15.21% above its $54.06 GF Value; BAC slid roughly 1.2% intraday on that piece. The underlying fundamentals remain outstanding — six straight EPS beats with an average surprise of ~7.5%, FY2026 consensus raised from $4.48 to $4.68 over 60 days on 18 upward and zero downward revisions, and record Q2 NII of $16B — and the Anthropic $15B revolving credit facility (BAC named as a possible participant alongside Morgan Stanley and JPMorgan) is fresh evidence the capital-markets fee pipeline is expanding. Technically, the picture has softened from confirmed repair to neutral: MACD histogram has now contracted four straight sessions (-0.4375 → -0.1302) and RSI pulled back to 52.89, but OBV fell to 1,004.9M from 1,030.8M and the SMA20 flip back to resistance removes the aggressive add trigger. We maintain BUY at a trimmed score of 75, with the 1-month view moved to HOLD pending either a higher-volume reclaim of SMA20/$63.55 or a pullback into $61.50-62.75; the October 14 earnings report is 39 days away, the $68-70 target cluster (mean $68.77, UBS $70) remains the profit zone, and the $59.50 stop below EMA50 ($61.05) defines thesis invalidation.